Non-follicular lymphoma

CD2_NONFOLLICULAR_LYMPHOMA

neoplasm of mature B-cells: A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C83 Hospital discharge: ICD-9 — 200 Hospital discharge: excluded ICD-9 — 200A Cause of death: ICD-10 — C83 Cause of death: ICD-9 — 200 Cause of death: excluded ICD-9 — 200A 2 out of 7 registries used, show all original rules.	3604
4. Check minimum number of events None	3604
5. Include endpoints None	3604
6. Filter based on genotype QC (FinnGen only)	3604

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: C81-C96
Name in latin: Lymphoma non-Hodgkin diffusum

NAME	CD2_NONFOLLICULAR_LYMPHOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C83
HD_ICD_9	200
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	200A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C83
COD_ICD_9	200
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	200A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-follicular lymphoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3604	1498	2106
Unadjusted period prevalence (%)	0.75	0.51	0.93
Median age at first event (years)	66.07	64.47	67.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3254: Matched controls
32539

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

323.0

400

M04AA01

ATC

allopurinol; systemic

8.7

323.0

1520

2972

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

323.0

454

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

16384.0

323.0

1820

XW000

NOMESCO Finland

Bone marrow biopsy

27.5

323.0

1100

592

JN4BD

NOMESCO Finland

Extensive body CT

9.9

323.0

1349

2170

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

69.9

323.0

678

122

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

25.6

323.0

595

282

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.6

323.0

767

1014

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

4069.3

323.0

373

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

176.7

323.0

2383

495

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

323.0

365

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

47.2

323.0

443

108

L03AA02

ATC

filgrastim; parenteral

48.8

323.0

993

290

WW500

NOMESCO Finland

Blood transfusion

16.3

323.0

728

565

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

139.8

323.0

488

A03FA01

ATC

metoclopramide; systemic, rectal

7.9

323.0

1710

4005

L03AA13

ATC

pegfilgrastim; parenteral

29.6

323.0

895

412

A04AA01

ATC

ondansetron; systemic, rectal

10.0

323.0

763

967

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

323.0

333

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

323.0

309

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

26.2

323.0

1036

569

JN6AD

NOMESCO Finland

CT of torso and neck

40.7

323.0

414

116

1XC02

NOMESCO Finland

133.5

323.0

357

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

62.6

323.0

873

189

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

64.7

308.1

358

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

307.2

290

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

33.3

298.8

397

135

D70.82

ICD-10 Finland

Drug-induced neutropenia

28.8

290.4

401

158

JN4AD

NOMESCO Finland

Body CT examination

7.0

282.5

781

1404

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

31.3

271.3

366

131

PJA10

NOMESCO Finland

Exploration of lymph nodes

38.1

270.5

348

102

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

168.7

266.5

278

H02AB06

ATC

prednisolone; systemic

3.7

263.5

2156

11305

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

11.3

261.3

522

543

ZX120

NOMESCO Finland

Intravenous

5.9

244.6

779

1655

A04AA02

ATC

granisetron; systemic, transdermal

8.0

242.4

596

885

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

237.1

875

2196

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

228.9

217

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

39.7

227.7

290

L03AA14

ATC

lipegfilgrastim; parenteral

20.7

213.7

326

174

R50.9

ICD-10 Finland

Fever, unspecified

4.5

213.0

899

2556

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

17.8

185.9

299

184

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.0

174.7

1447

6847

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.6

165.2

462

800

C82.1

ICD-10 Finland

Follicular lymphoma grade II

39.6

163.4

208

WW300

NOMESCO Finland

Transfer of autologic stem cells

72.0

160.8

184

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

18.5

152.5

241

140

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

27.9

145.7

202

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

86.8

140.6

157

N02AA05

ATC

oxycodone; systemic

3.3

140.4

851

3137

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

18.0

139.1

222

132

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

138.7

752

2543

H02AB07

ATC

prednisone; oral

3.4

137.2

801

2863

J05AB11

ATC

valaciclovir; oral

3.7

137.0

688

2183

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

130.2

1828

11118

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

25.6

129.7

184

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

127.9

122

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

44.8

124.3

154

A02BC02

ATC

pantoprazole; systemic

2.5

123.1

2359

16654

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

11.6

122.3

235

216

H02AB02

ATC

dexamethasone; systemic

3.8

121.3

592

1816

ZX112

NOMESCO Finland

Subcutaneous

9.7

119.7

253

279

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

11.5

115.7

223

206

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

16.1

111.6

185

121

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

107.9

103

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

21.4

106.2

159

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.8

105.2

383

885

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

6.8

104.0

276

435

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

14.3

102.8

179

132

XX9CD

NOMESCO Finland

Very extensive complementary CT

266.1

101.3

103

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.3

98.1

399

1027

J01MA12

ATC

levofloxacin; systemic

2.6

98.0

896

4160

212

Kela drug reimbursment

Gout

7.5

97.2

242

347

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

96.2

253

393

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

60.4

94.6

111

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.6

91.8

248

399

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

49.9

91.6

111

D70.89

ICD-10 Finland

Neutropenic splenomegaly

14.7

90.4

155

110

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

+∞

88.9

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

85.8

WF003

NOMESCO Finland

Adjuvant radiotherapy

5.5

84.1

266

522

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

62.4

83.2

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

33.1

82.6

109

B72

ICPC

Hodgkin Lymphoma

102.8

82.3

L01AA02

ATC

chlorambucil; oral

48.5

81.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

52.0

79.9

XX3DW

NOMESCO Finland

Time consuming IT work

2.9

75.6

510

1933

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

75.3

WF049

NOMESCO Finland

Radiotherapy of metastasis

5.5

75.1

235

454

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

74.2

WF002

NOMESCO Finland

Radical radiotherapy

3.8

73.6

335

945

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

73.2

WW409

NOMESCO Finland

Other aferesis

48.1

73.1

Z51.5

ICD-10 Finland

Palliative care

3.6

72.8

356

1066

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.5

71.8

363

1116

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

69.9

71.6

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

245.3

70.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.4

69.1

219

429

ZX108

NOMESCO Finland

Inhalation

20.0

69.1

105

TAB00

NOMESCO Finland

Lumbar puncture

4.8

68.2

243

542

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.0

68.1

292

779

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

67.9

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

67.9

TGC00

NOMESCO Finland

Bronchial lavation

5.6

67.6

206

385

A41.9

ICD-10 Finland

Sepsis, unspecified

4.6

67.3

248

572

L01CB01

ATC

etoposide; systemic

21.0

66.9

100

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.6

66.0

139

151

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

65.8

WZC30

NOMESCO Finland

Teaching

2.5

65.6

573

2518

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

33.5

64.8

WF004

NOMESCO Finland

Palliative radiotherapy

6.8

63.0

165

253

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

28.4

62.9

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

62.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.3

62.7

250

623

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

61.6

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

61.6

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

163.1

61.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

60.9

987

5766

J05AB01

ATC

aciclovir; systemic

2.2

59.8

736

3820

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

59.8

504

2164

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

11.7

59.7

113

100

YNB10

NOMESCO Finland

Collection of stem cells for transplant

94.7

59.0

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

108.8

59.0

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

12.1

58.6

109

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

58.1

874

4940

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

93.3

58.0

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

57.9

806

4407

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

13.7

57.5

101

A07AA02

ATC

nystatin; oral

3.2

56.2

322

1080

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

56.2

981

5864

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

55.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

55.0

297

954

B01AB05

ATC

enoxaparin; parenteral

1.9

54.0

1129

7182

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.8

53.6

387

1510

D69.5

ICD-10 Finland

Secondary thrombocytopenia

27.0

53.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.3

52.3

285

921

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

27.2

52.2

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

52.2

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

52.2

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

51.2

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

51.7

51.0

JN4CD

NOMESCO Finland

Very extensive body CT

3.7

50.2

230

647

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

44.3

49.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.3

49.2

122

173

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

+∞

49.1

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

49.1

1AA09

NOMESCO Finland

172.6

49.0

WW402

NOMESCO Finland

Leucoferesis

53.6

48.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

47.9

453

2051

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

47.7

428

1886

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

47.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.5

46.3

170

390

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

45.4

634

3424

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

49.9

44.9

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

44.9

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

31.6

44.6

B01AB10

ATC

tinzaparin; parenteral

2.8

43.8

309

1183

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

11.5

43.4

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

433.2

43.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

42.2

1027

6740

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

55.2

41.5

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

40.7

390

Kela drug reimbursment

Ibrutinib

45.2

40.1

TPX15

NOMESCO Finland

Removal of vascular injection port

16.7

39.9

WW200

NOMESCO Finland

Immunization

4.3

39.6

152

364

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

52.9

39.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.8

39.5

102

154

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

38.8

418

2005

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.7

38.7

137

303

JMA10

NOMESCO Finland

Transabdominal total splenectomy

14.3

38.7

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

38.6

H02AB09

ATC

hydrocortisone; systemic

5.0

38.5

129

269

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

12.6

38.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

37.9

673

3951

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

8.2

37.4

106

J01MA14

ATC

moxifloxacin; systemic

2.4

37.4

352

1577

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

70.7

37.0

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

36.5

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

60.7

36.2

ZX131

NOMESCO Finland

Intrathecal

187.0

35.8

ED1AA

NOMESCO Finland

Mandipular X-ray examination

12.0

35.8

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

15.4

35.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.3

35.6

138

334

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

34.9

310

1349

WX110

NOMESCO Finland

Local anesthesy

1.6

34.6

1997

16268

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

34.4

FM1FN

NOMESCO Finland

Heart function isotope examination

13.3

34.1

9699/3-C16.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of stomach, NOS

+∞

33.4

N02BE01

ATC

paracetamol; systemic, rectal

1.7

33.1

2689

23816

EMA10

NOMESCO Finland

Biopsy of tonsil

22.1

33.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

32.7

1471

11201

C03CA01

ATC

furosemide; systemic

1.6

32.5

1080

7614

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

15.8

32.5

9680/3-C62.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of testis, NOS

+∞

32.3

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

32.3

1512

Kela drug reimbursment

Ibrutinib

40.5

32.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

31.7

202

721

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

27.2

31.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

31.3

402

2070

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.7

31.1

139

383

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

28.3

31.1

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

161.5

30.7

L01XE27

ATC

[U] ibrutinib; oral

46.7

30.6

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

7.2

30.6

106

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

31.1

30.3

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

30.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

28.9

308

1460

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

11.4

28.3

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

28.2

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

11.2

28.0

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

64.6

27.9

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

33.1

27.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

27.6

1163

8613

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

8.6

27.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

27.1

104

250

L01BB05

ATC

fludarabine; systemic

22.6

26.5

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

20.8

26.5

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

11.3

26.1

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

8.3

26.0

R06AE07

ATC

cetirizine; oral

1.5

26.0

1192

8966

B02.9

ICD-10 Finland

Zoster without complication

2.4

25.9

227

975

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

40.4

25.8

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

136.1

25.6

1CX01

NOMESCO Finland

33.3

25.5

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.3

25.5

131

405

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

25.0

J02AC01

ATC

fluconazole; systemic

1.5

25.0

969

6995

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

24.8

183

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

252.0

24.7

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

7.2

24.6

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

24.0

AAA10

NOMESCO Finland

Biopsy through craniotomy

37.8

23.9

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

12.1

23.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

23.6

142

490

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

125.9

23.6

JFB00

NOMESCO Finland

Partial resection of small intestine

4.3

23.5

212

3AA13

NOMESCO Finland

19.6

23.4

A79

ICPC

Malignancy NOS

5.0

23.2

156

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

28.4

23.1

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

22.9

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

+∞

22.9

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

15.6

22.8

Z52.89

ICD-10 Finland

Donor of other organ or tissue

40.4

22.7

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

120.8

22.6

9591/3-C16.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS

120.8

22.6

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

23.1

22.6

KFC00

NOMESCO Finland

Unilateral orchiectomy

8.6

22.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

22.5

347

1911

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.6

22.4

102

287

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

22.2

969

7140

J01DB01

ATC

cefalexin; oral

1.5

22.1

2446

21752

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

21.9

9680/3-C17.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of small intestine, NOS

+∞

21.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

21.9

1014

7569

4701

FHL

Neck lymph node removal

18.5

21.7

JAH00

NOMESCO Finland

Laparotomy

3.3

21.7

111

343

KA1FN

NOMESCO Finland

Isotope renography

7.0

21.4

N05CF01

ATC

zopiclone; oral

1.5

21.4

1022

7669

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.5

21.1

173

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.9

20.8

130

461

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

20.6

307

1664

9591/3-C09.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS

110.7

20.6

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.9

20.5

217

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

11.3

20.4

CAA30

NOMESCO Finland

Biopsy of orbit

57.9

19.9

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

19.8

741

5252

9680/3-C42.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of spleen

+∞

19.8

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

19.8

9680/3-C49.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck

+∞

19.8

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

19.8

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

73.9

19.7

127

Kela drug reimbursment

Transplant complication

4.4

19.6

168

A41.8

ICD-10 Finland

Other specified sepsis

3.7

19.6

231

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.2

19.5

103

326

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.2

19.5

178

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

8.5

19.4

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

15.6

19.2

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.1

19.2

122

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.5

19.0

150

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.6

19.0

146

L01EL01

ATC

ibrutinib; oral

34.5

18.9

GEA00

NOMESCO Finland

Mediastinoscopy

9.6

18.8

9679/3-C38.3

ICD-O-3

Mediastinal large B-cell lymphoma of mediastinum, NOS

+∞

18.8

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

18.8

C82.7

ICD-10 Finland

Other types of follicular lymphoma

70.3

18.7

9101

FHL

Bone biopsy

28.0

18.7

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

17.2

18.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

18.6

1301

10443

1BC01

NOMESCO Finland

100.6

18.6

372

Kela drug reimbursment

Idelalisib

100.6

18.6

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

191.0

18.5

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

5.5

18.4

V03AF03

ATC

calcium folinate; systemic

13.6

18.2

WX002

NOMESCO Finland

Sedation and analgesia

1.6

18.2

615

4246

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.8

18.1

116

419

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

52.8

17.9

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

17.7

E83.50

ICD-10 Finland

Hypercalcemia

4.4

17.6

148

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

180.9

17.5

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.6

17.4

218

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.5

17.4

244

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

17.4

196

952

J02AC03

ATC

voriconazole; systemic

17.0

17.4

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

18.7

17.3

120

Kela drug reimbursment

Hypogammaglobulinaemia

18.7

17.3

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

17.2

298

1706

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

17.2

136

557

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

31.6

17.0

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

14.1

16.8

JAH21

NOMESCO Finland

Staging laparoscopy

63.6

16.7

9699/3-C34.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lung, NOS

+∞

16.7

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

16.7

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

16.7

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

+∞

16.7

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

16.7

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

16.7

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

6.1

16.6

N03AX16

ATC

pregabalin; oral

1.5

16.6

677

4866

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

16.6

106

383

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

16.4

16.5

J01CA04

ATC

amoxicillin; systemic

1.4

16.4

2276

20356

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.2

16.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

12.8

16.1

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

18.6

16.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.5

15.8

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

15.8

147

653

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

15.6

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

15.6

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

17.3

15.6

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

160.7

15.5

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

160.7

15.5

C82

ICD-10 Finland

Follicular lymphoma

160.7

15.5

9699/3-C42.1

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of bone marrow

160.7

15.5

R4110

NOMESCO Finland

Physiotherapy

1.4

15.5

766

5718

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.5

15.4

204

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

38.2

15.4

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.5

15.3

205

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

28.7

15.2

ZXA00

NOMESCO Finland

Right side

1.4

15.1

835

6359

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

23.5

15.1

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

20.1

15.1

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

15.1

192

982

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

14.9

248

1398

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

14.9

113

453

A02BA02

ATC

ranitidine; systemic

1.5

14.8

607

4356

B02

ICPC

Lymph gland(s) enlarged/painful

6.7

14.8

JAH01

NOMESCO Finland

Laparoscopy

2.5

14.6

114

464

9699/3-C07.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of parotid gland

+∞

14.6

9699/3-C69.6

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of orbit, NOS

+∞

14.6

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

6.6

14.6

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

11.9

14.5

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

150.6

14.5

L01XX47

ATC

[U] idelalisib; oral

150.6

14.5

ZX080

NOMESCO Finland

Image guided radiotherapy

3.1

14.4

254

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

14.3

485

3334

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.5

14.3

113

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

19.2

14.2

D73.1

ICD-10 Finland

Hypersplenism

22.3

14.2

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

10.5

14.2

CFA20

NOMESCO Finland

Biopsy of conjunctiva

13.4

14.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

14.1

545

3854

WX402

NOMESCO Finland

General anaesthesia

1.6

14.1

431

2892

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

14.5

14.0

B74

ICPC

Malignant neoplasm blood other

14.5

14.0

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

14.0

237

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

10.1

13.9

A02BC01

ATC

omeprazole; systemic

1.4

13.9

835

6439

A05AA02

ATC

ursodeoxycholic acid; oral

4.1

13.9

130

TGD00

NOMESCO Finland

Needle biopsy of lung

5.9

13.9

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

12.7

13.9

UJF32

NOMESCO Finland

Coloscopy

1.4

13.8

798

6115

TK800

NOMESCO Finland

Hemodialysis

2.9

13.7

286

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

13.7

521

3673

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.2

13.6

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

75.4

13.6

C82.0

ICD-10 Finland

Follicular lymphoma grade I

75.4

13.6

R4190

NOMESCO Finland

Nutritional therapy

2.6

13.6

377

9680/3-C38.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS

+∞

13.5

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

13.5

128

577

R50.8

ICD-10 Finland

Other specified fever

7.2

13.5

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

10.9

13.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

10.9

13.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

13.4

938

7415

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.1

13.4

125

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

13.4

194

1043

A06AD11

ATC

lactulose; oral

1.5

13.4

466

3223

Z51.0

ICD-10 Finland

Radiotherapy session

3.8

13.4

145

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

25.8

13.4

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.9

13.3

291

EMB10

NOMESCO Finland

Tonsillectomy

2.5

13.3

105

431

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

40.2

13.1

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

13.0

124

560

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.0

12.9

161

816

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

12.8

183

979

B01AB04

ATC

dalteparin; parenteral

2.0

12.8

164

843

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.1

12.7

117

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

6.0

12.7

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

12.3

12.6

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

12.3

12.6

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.7

12.6

148

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.5

12.5

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

12.5

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

12.5

9680/3-C49.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip

+∞

12.5

1DB01

NOMESCO Finland

+∞

12.5

C88.4

ICD-10 Finland

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]

+∞

12.5

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

+∞

12.5

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

12.5

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

17.4

12.5

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

130.5

12.4

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

6.9

12.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.3

936

7483

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.1

12.2

117

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.7

12.2

142

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

4.2

12.2

108

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

12.2

478

3388

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

12.1

599

4443

WX892

NOMESCO Finland

Monitored bed care

1.7

12.1

231

1362

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

8.7

12.0

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

12.0

156

807

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.3

11.9

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.9

11.9

125

EBA10

NOMESCO Finland

Surgical removal of tooth

1.7

11.9

252

1531

WX882

NOMESCO Finland

High dependency care

2.4

11.9

100

426

ELB30

NOMESCO Finland

Excision of submandibular gland

6.8

11.9

D73.9

ICD-10 Finland

Disease of spleen, unspecified

46.8

11.9

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

10.5

11.7

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

6.6

11.7

J35.1

ICD-10 Finland

Hypertrophy of tonsils

5.0

11.7

J01MA02

ATC

ciprofloxacin; systemic

1.3

11.6

1151

9554

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

7.7

11.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.6

11.6

337

WX199

NOMESCO Finland

Other local analgesia

2.5

11.6

374

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

11.5

150

774

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.4

11.5

421

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

11.5

277

1747

9680/3-C30.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasal cavity

+∞

11.5

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

11.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

11.4

285

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

11.3

643

4891

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

11.3

404

WX720

NOMESCO Finland

Own respiration

2.2

11.2

114

531

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

11.2

116

544

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.4

11.2

ZX114

NOMESCO Finland

Intramuscular

3.4

11.1

159

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

25.1

11.1

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

12.7

11.1

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

11.1

294

L01AA01

ATC

cyclophosphamide; systemic

6.1

11.0

L04AD01

ATC

ciclosporin; systemic

2.9

11.0

221

9591/3-C42.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of bone marrow

43.4

10.9

B02

ICD-10 Finland

Zoster [herpes zoster]

2.2

10.9

104

471

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

10.9

163

888

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.5

10.8

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

17.9

10.7

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

60.2

10.6

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

60.2

10.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

10.4

167

931

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

10.4

9680/3-C17.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of duodenum

+∞

10.4

3AX16

NOMESCO Finland

+∞

10.4

9680/3-C17.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of ileum

+∞

10.4

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

10.4

255

1620

399

Kela drug reimbursment

Venetoclax

32.6

10.3

ZXA05

NOMESCO Finland

Left side

1.3

10.3

755

5972

Z31.6

ICD-10 Finland

General counselling and advice on procreation

8.2

10.3

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.0

10.3

186

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

5.1

10.3

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

18.8

10.2

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.2

10.2

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

23.4

10.2

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.4

10.1

370

R05

ICD-10 Finland

Cough

1.4

10.1

512

3803

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

10.1

226

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

10.1

282

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

10.1

241

B73

ICPC

Leukaemia

10.6

9.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

9.7

168

960

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

13.4

9.7

D73.0

ICD-10 Finland

Hyposplenism

55.1

9.6

ENA10

NOMESCO Finland

Biopsy of pharynx

6.8

9.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

9.6

327

JN4DD

NOMESCO Finland

Scout CT scan of torso

11.4

9.5

C10AA07

ATC

rosuvastatin; oral

0.7

9.5

425

5621

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

7.1

9.5

C90.0

ICD-10 Finland

Multiple myeloma

3.3

9.4

142

9699/3-C69.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of conjunctiva

100.3

9.4

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.3

9.4

C69.60

ICD-10 Finland

Malignant tumor in orbit without histology

+∞

9.4

9673/3-C80.9

ICD-O-3

Mantle cell lymphoma of unknown primary site

+∞

9.4

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

9.4

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

+∞

9.4

L04AA01

ATC

[U] ciclosporin; systemic

3.1

9.3

165

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

12.4

9.3

Z51.88

ICD-10 Finland

Other specified medical care

2.6

9.3

246

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

21.7

9.3

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

9.3

305

2078

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

10.7

9.3

HA1AA

NOMESCO Finland

X-ray mammography

1.7

9.3

175

1032

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

9.2

176

1038

L04AA06

ATC

mycophenolic acid; systemic

2.9

9.2

182

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

7.3

9.2

WF099

NOMESCO Finland

Other radiotherapy

4.8

9.1

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.3

9.1

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

9.0

215

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

9.0

370

L01XX52

ATC

venetoclax; oral

36.8

9.0

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

36.8

9.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.6

9.0

110

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.2

9.0

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

18.6

8.9

JAH20

NOMESCO Finland

Staging laparotomy

24.1

8.9

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

6.1

8.9

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

12.5

8.9

GD6AD

NOMESCO Finland

CT of chest and neck

8.0

8.8

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

3.7

8.8

102

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.3

8.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

8.7

128

695

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

14.0

8.7

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

50.1

8.7

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.7

8.6

210

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.7

8.6

189

1167

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

8.6

195

1211

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.2

8.6

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

8.5

272

P01BA02

ATC

hydroxychloroquine; oral

1.6

8.5

209

1325

A06AH03

ATC

naloxegol; oral

3.3

8.5

121

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

27.6

8.5

B59

ICD-10 Finland

Pneumocystosis

27.6

8.5

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.0

8.5

160

SPAT1153

SPAT

Removal of sutures

1.3

8.5

927

7727

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

20.1

8.5

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

5.1

8.4

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

8.4

197

1234

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

90.3

8.4

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

90.3

8.4

9689/3-C42.1

ICD-O-3

Splenic marginal zone B-cell lymphoma of bone marrow

90.3

8.4

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

90.3

8.4

9591/3-C17.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS

90.3

8.4

1CA02

NOMESCO Finland

90.3

8.4

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

12.8

8.4

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.1

8.3

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

8.3

9680/3-C49.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS

+∞

8.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

3AF07

NOMESCO Finland

+∞

8.3

9680/3-C49.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax

+∞

8.3

9699/3-C80.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of unknown primary site

+∞

8.3

9680/3-C48.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of retroperitoneum

+∞

8.3

9680/3-C07.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of parotid gland

+∞

8.3

9670/3-C42.1

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of bone marrow

+∞

8.3

9699/3-C44.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of skin, NOS

+∞

8.3

9591/3-C62.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS

+∞

8.3

9699/3-C08.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of submandibular gland

+∞

8.3

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

8.3

R11

ICD-10 Finland

Nausea and vomiting

1.6

8.2

195

1225

CBA10

NOMESCO Finland

Biopsy of eyelid

3.5

8.2

103

A03

ICPC

Fever

1.5

8.2

317

2233

A02BC05

ATC

esomeprazole; systemic

1.3

8.2

1076

9165

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

8.2

175

1071

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.2

199

1260

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.1

8.1

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.6

8.1

216

B04

ICPC

Blood symptom/complaint

5.4

8.1

A07AA09

ATC

vancomycin; oral

2.8

8.1

170

D11.70

ICD-10 Finland

Gland sublingual

8.1

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

17.2

8.1

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

8.1

364

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

6.8

8.1

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

5.0

8.0

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.8

8.0

172

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.1

8.0

438

G53.0

ICD-10 Finland

Postzoster neuralgia

3.9

7.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.7

7.9

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

7.0

7.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.8

384

2836

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

7.4

7.7

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.0

7.6

460

I50.1

ICD-10 Finland

Left ventricular failure

1.7

7.6

151

903

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.5

7.6

215

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

11.9

7.6

J01FF01

ATC

clindamycin; systemic

1.3

7.6

719

5872

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

7.5

122

687

CKA10

NOMESCO Finland

Biopsy of vitreous body

8.9

7.5

A04AD12

ATC

aprepitant; systemic

2.5

7.5

216

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.7

7.5

177

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

5.4

7.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.5

940

7945

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.3

7.5

293

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

4.8

7.4

C88.7

ICD-10 Finland

Other malignant immunoproliferative diseases

80.3

7.4

L57.0

ICD-10 Finland

Actinic keratosis

1.4

7.4

301

2146

S18

ICPC

Laceration/cut

1.2

7.3

1177

10227

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

V03AB28

ATC

+∞

7.3

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

7.3

9680/3-C41.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints

+∞

7.3

9680/3-C49.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder

+∞

7.3

9680/3-C49.6

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS

+∞

7.3

9680/3-C49.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen

+∞

7.3

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

7.3

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

+∞

7.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

7.3

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

9680/3-C11.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS

+∞

7.3

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

7.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

7.3

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.1

7.3

349

9109

FHL

Other measure in this category

10.9

7.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

7.2

427

3251

ZX121

NOMESCO Finland

Central venous catheter

5.1

7.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.1

7.2

3AA02

NOMESCO Finland

15.8

7.2

WE100

NOMESCO Finland

Profylactic cytostatic therapy

15.8

7.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

7.2

352

6BA02

NOMESCO Finland

5.4

7.2

ZX130

NOMESCO Finland

Epidural

5.8

7.2

5702

FHL

Local lymph node removal (eg armpit, groin)

5.8

7.2

N03AX14

ATC

levetiracetam; systemic

2.2

7.2

320

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

30.1

7.1

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

30.1

7.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.1

473

3666

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

6.6

7.1

R59

ICD-10 Finland

Enlarged lymph nodes

12.0

7.1

1AA01

NOMESCO Finland

12.0

7.1

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

8.8

7.0

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2.5

7.0

218

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

7.0

RS220

NOMESCO Finland

2.8

7.0

146

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

6.3

6.9

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.9

969

8282

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

5.2

6.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

6.9

1088

9419

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.2

6.9

108

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.2

6.9

312

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

7.5

6.9

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

13.8

6.9

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

13.8

6.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.8

381

2871

L03AA04

ATC

8.3

6.8

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.6

6.8

179

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

6.8

112

636

6753

FHL

Transabdominal splenectomy

9.3

6.8

1518

Kela drug reimbursment

40.1

6.8

J94.0

ICD-10 Finland

Chylous effusion

40.1

6.8

ZXC40

NOMESCO Finland

Use of ultrasound

3.7

6.7

JN5AP

NOMESCO Finland

Total body PET (1 picture)

16.7

6.7

5701

FHL

Local exploration of lymph nodes (includes biopsy)

16.7

6.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.7

416

3192

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

6.7

111

ZXC95

NOMESCO Finland

Use of surgical navigator

3.0

6.6

117

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.9

6.6

132

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

7.8

6.6

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

5.5

6.6

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

5.5

6.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

3.7

6.6

ELB00

NOMESCO Finland

Excision or exploration of lesion of salivary gland

8.7

6.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

6.5

159

2342

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

6.5

127

758

PJD99

NOMESCO Finland

Excision of other lymph nodes

10.0

6.5

AA1AD

NOMESCO Finland

CT of head and brain

1.3

6.5

682

5629

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

6.5

134

816

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.7

6.5

148

H26.3

ICD-10 Finland

Drug-induced cataract

4.1

6.5

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

4.1

6.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.5

446

3475

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.4

6.4

210

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

70.0

6.4

D38.50

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of maxillary sinus

70.0

6.4

9690/3-C42.1

ICD-O-3

Follicular lymphoma, NOS, of bone marrow

70.0

6.4

1XX08

NOMESCO Finland

70.0

6.4

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

70.0

6.4

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.9

6.4

121

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

6.3

166

1076

C10AA01

ATC

simvastatin; oral

0.8

6.3

1082

12267

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

6.5

6.3

WX704

NOMESCO Finland

Intubation

1.6

6.3

176

1156

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

11.0

6.3

EL3AT

NOMESCO Finland

Salivary gland biopsy with ultrasound guidance

18.0

6.3

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

6.2

1CB01

NOMESCO Finland

+∞

6.2

1AD01

NOMESCO Finland

+∞

6.2

9680/3-C06.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mouth, NOS

+∞

6.2

9670/3-C77.3

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm

+∞

6.2

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.2

AAF35

NOMESCO Finland

Implantation of reservoir for intraventricular therapy

+∞

6.2

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.2

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

+∞

6.2

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

6.2

C69.09

ICD-10 Finland

Malignant tumor in conjunctival other or unspecified histology

+∞

6.2

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.1

6.2

100

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

26.7

6.2

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

26.7

6.2

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

26.7

6.2

2301

FHL

Lumbar puncture in anesthesia or operating room

26.7

6.2

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

6.2

491

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

7.0

6.2

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.9

6.1

122

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

3.9

6.1

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.4

6.0

C07AB07

ATC

bisoprolol; oral

1.2

6.0

1432

12873

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

214

30.27

322.70

2.4

2.1

35.9

25.6

5.99

196

(3006245) CD3-CD19+ cells/100 cells in Blood

213

30.53

322.13

2.4

2.0

11.5

11.6

0.01

185

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2807

16010

4.41

320.87

15.7

6.2

umol/l

10.7

12.0

5.37

2769

15184

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

348

166

23.10

307.65

3.3

1.8

e6/l

441.3

712.8

4.10

139

(3013115) Eosinophils [#/volume] in Blood

2871

15119

5.42

307.65

11.4

5.9

e9/l

0.2

22.27

2646

13109

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

476

150

36.41

307.65

2.4

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2365

3781

16.29

307.65

8.3

4.0

u/l

279.7

239.5

7.10

2309

3561

(3017143) Hepatitis C virus Ab [Presence] in Serum

1642

2487

11.29

307.65

1.5

1.6

—

(3022096) Basophils/100 leukocytes in Blood

2725

13358

5.26

307.65

11.0

6.0

0.7

0.81

2654

12401

(40768795) Lymph node Pathology biopsy report

808

220

47.05

307.65

1.4

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

447

187

27.15

307.65

2.4

1.9

28.0

43.0

3.07

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1514

1534

16.29

307.65

1.4

—

(3001604) Monocytes [#/volume] in Blood

2842

14575

5.49

307.65

10.5

5.7

e9/l

0.6

0.06

2598

12444

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

364

154

26.18

307.65

3.0

1.9

e6/l

575.8

519.0

0.35

302

127

(3019198) Lymphocytes [#/volume] in Blood

2854

14933

5.38

307.65

10.7

5.8

e9/l

1.9

0.36

2643

12988

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

412

433

10.61

307.65

1.4

u/ml

115.4

122.3

0.23

105

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

350

145

26.63

307.65

3.1

1.9

e9/l

0.2

0.22

302

125

(3045142) Bone marrow Pathology biopsy report

778

323

30.44

307.65

1.6

1.2

—

(3011412) CD3 cells [#/volume] in Blood

594

210

33.67

307.65

2.7

1.9

e9/l

1.1

1.0

0.49

411

113

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

620

540

13.66

307.65

5.0

5.2

iu/ml

2701.8

762.7

0.40

(3006315) Basophils [#/volume] in Blood

2848

14646

5.50

307.65

10.5

5.7

e9/l

0.0

13.48

2605

12525

(3006504) Eosinophils/100 leukocytes in Blood

2744

13714

5.19

307.65

11.3

6.0

2.6

2.9

5.84

2674

12707

(21494814) CD8 cells/100 lymphocytes in Specimen

279

37.25

307.65

2.1

1.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

329

329.04

307.65

8.5

18.3

umol/l

0.4

0.22

320

(3042111) Morphology [Interpretation] in Bone marrow Narrative

765

547

17.48

307.65

1.7

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

2755

13777

5.24

307.65

11.8

6.3

9.7

8.9

23.72

2683

12819

(3026493) Urate [Moles/volume] in Serum or Plasma

2197

8146

5.35

307.65

6.2

2.8

umol/l

807.2

6013.2

15.75

2125

6927

(3010503) CD19 cells [#/volume] in Blood

389

138

31.48

307.65

2.8

1.9

e9/l

0.2

0.20

383

130

(3018010) Neutrophils/100 leukocytes in Blood

2714

13854

4.88

307.65

10.5

5.9

56.3

58.1

9.45

2642

12871

(3002030) Lymphocytes/100 leukocytes in Blood

2759

14065

5.10

307.65

11.6

6.1

27.1

26.6

1.08

2687

13002

(42870588) Differential panel, method unspecified - Blood

2366

10275

4.79

307.65

10.4

5.8

—

(40765096) Chromosome analysis panel by Banding

254

34.96

307.65

1.2

1.1

—

(4035726)

1399

2677

7.91

307.65

1.7

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1750

3220

9.62

307.65

1.5

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1212

2096

8.21

307.65

4.3

2.7

g/l

8.7

10.7

29.51

1163

1899

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

254

41.33

307.65

2.2

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

486

153

36.56

307.65

2.3

2.0

14.8

13.5

0.44

194

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

675

158

52.34

307.65

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1231

3958

4.20

307.65

3.8

2.5

1.8

0.08

1157

3477

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

462

494

10.58

307.65

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

542

425

14.83

307.65

2.6

u/ml

4750.9

1194.7

1.08

(3023520) Reticulocytes [#/volume] in Blood

1041

2991

4.49

307.65

3.8

2.5

e9/l

69.7

69.0

0.24

878

2275

(3017181) Myelocytes/100 leukocytes in Blood

1007

2594

5.00

307.65

6.2

4.0

1.2

0.9

2.04

635

738

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

319

144

24.21

307.65

3.9

2.4

33.1

41.5

3.59

125

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1678

2714

10.70

307.65

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

490

159

35.51

307.65

2.3

1.9

73.2

70.2

1.14

469

147

(3028026) IgM [Mass/volume] in Serum or Plasma

868

1662

6.56

307.65

3.2

1.8

g/l

1.6

1.3

1.23

816

1498

(3013650) Neutrophils [#/volume] in Blood by Automated count

2938

17039

4.92

307.65

26.3

8.7

e9/l

3.5

4.3

62.57

2745

14783

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

479

732

7.39

305.43

2.3

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

881

2356

4.63

305.42

6.0

3.8

0.7

0.6

1.14

443

514

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

484

762

7.18

300.09

2.3

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

894

2475

4.47

295.58

6.4

4.0

0.2

0.1

3.71

578

687

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1386

5224

3.69

295.32

7.2

3.2

mmol/l

0.8

2.17

1335

4861

(3024561) Albumin [Mass/volume] in Serum or Plasma

2486

13606

3.67

289.06

8.8

4.9

g/l

33.8

34.9

16.27

2400

12622

(3004809) Band form neutrophils/100 leukocytes in Blood

401

542

8.20

284.45

4.8

3.5

1.5

1.7

0.43

334

405

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

400

563

7.87

273.78

2.3

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

477

825

6.51

269.27

1.7

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

262

236

11.89

251.45

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

815

2384

4.13

246.64

2.3

2.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

257

243

11.31

238.66

1.7

1.8

mg/l

4.0

4.6

0.98

244

233

(3000060) B lymphocytes [#/volume] in Blood

149

33.75

233.18

2.4

1.9

e6/l

646.7

198.9

0.55

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

332

463

7.80

228.25

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

123

66.99

224.63

1.8

2.6

—

(3023368) Bacteria identified in Blood by Culture

1822

9240

2.97

220.89

8.3

4.4

—

(3025159) Blasts/100 leukocytes in Blood

760

2321

3.88

214.11

6.3

4.1

0.1

0.3

0.61

457

572

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1106

4319

3.25

211.97

7.1

6.0

mmol/l

1.0

0.74

1071

4002

(3048929) Epstein Barr virus Ab [Presence] in Serum

373

644

6.35

209.54

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

338

543

6.77

203.69

1.9

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

300

431

7.50

200.46

1.3

1.2

u/ml

288.9

270.7

0.33

182

260

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2527

15821

3.00

198.05

12.7

7.0

mmol/l

1.2

9.25

2136

13301

(3020630) Protein [Mass/volume] in Serum or Plasma

832

2861

3.48

194.41

2.7

2.6

g/l

64.2

66.2

7.90

789

2595

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

296

459

6.94

184.15

1.9

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2337

14390

2.78

182.43

11.0

6.2

mmol/l

1.2

7.01

2253

12968

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

142

19.67

182.09

3.8

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1305

6011

2.84

181.62

9.8

4.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

445

6.97

180.94

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

246

324

8.08

176.99

2.3

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

237

300

8.39

176.27

2.4

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

252

350

7.67

173.15

5.4

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1201

5460

2.80

169.37

2.9

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

698

2330

3.48

169.03

2.3

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

204

233

9.22

164.60

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

252

374

7.17

163.02

1.9

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

80.07

161.20

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

115

24.21

161.10

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

454

1169

4.30

159.54

2.3

2.6

—

(3018418) pH of Serum or Plasma

1694

9339

2.54

158.86

8.6

4.1

7.4

1.20

415

1816

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

266

434

6.54

157.23

1.9

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

169

160

11.03

156.20

4.3

3.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1817

10446

2.49

154.26

7.3

3.4

mmol/l

2.3

2.4

0.35

1694

9000

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

191

219

9.15

153.56

2.6

2.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

277

488

6.07

151.52

2.0

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

185

210

9.23

149.86

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1078

4938

2.69

146.46

2.5

1.5

g/l

2.0

2.6

12.05

877

2881

(3017354) Segmented neutrophils/100 leukocytes in Blood

227

339

7.08

145.81

4.9

3.5

54.4

57.4

0.75

153

205

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

16.36

143.41

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1204

5885

2.57

142.57

5.3

3.1

mmol/l

2.5

4.04

1161

5141

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

883

3792

2.76

134.86

2.6

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

881

3802

2.74

133.07

2.5

1.7

—

(40758292) HTLV I+II Ab panel - Serum

25.10

132.19

1.5

1.3

—

(44790049)

215

339

6.68

131.07

1.8

1.4

—

(44790047)

215

339

6.68

131.07

1.8

1.4

—

(44790048)

215

339

6.68

131.07

1.8

1.4

—

(44806118)

215

339

6.68

131.07

1.8

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2148

13952

2.34

130.00

7.2

4.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

314

711

4.74

129.21

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

2030

12904

2.31

128.90

19.1

10.2

e9/l

0.0

1.05

1738

10529

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

13.43

127.52

1.9

u/ml

5196.4

36780.2

0.43

(3037756) Immunofixation for Serum or Plasma

320

744

4.62

127.41

1.4

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1644

9645

2.30

125.45

4.6

2.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3026

23202

2.90

123.16

20.4

7.7

u/l

83.7

80.0

3.81

2970

21804

(40758558) Short blood count panel - Blood

1369

7481

2.34

123.03

19.4

6.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2883

21653

2.66

120.91

7.1

4.2

mm/h

16.9

13.4

19.25

2779

19885

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

313

749

4.48

120.03

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

267

7.17

119.87

2.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

267

7.17

119.87

2.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

267

7.17

119.87

2.7

1.5

—

(21494434) Karyotype in Bone marrow

193

314

6.44

113.98

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

423

1342

3.44

108.43

2.6

2.5

g/l

7.3

7.4

0.76

330

1009

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

422

1341

3.43

107.88

2.6

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

1340

3.43

107.33

2.6

2.5

g/l

3.7

3.8

0.32

324

967

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

381

1138

3.63

107.14

2.7

2.5

g/l

1.4

1.1

0.71

337

982

(3037692) Legionella sp identified in Specimen by Organism specific culture

116

110

10.86

106.87

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

439

1441

3.33

106.50

2.7

1.9

ug/l

2.7

2.4

0.11

409

1266

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

396

1245

3.45

102.77

2.7

2.5

g/l

3.3

3.1

3.05

327

992

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

133

162

8.49

101.65

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

369

1119

3.56

101.23

2.7

3.5

mg/l

38.5

65.6

1.21

300

906

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1298

7416

2.17

100.11

4.3

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

367

1119

3.54

99.80

2.7

3.5

mg/l

58.0

57.3

0.03

301

902

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

22.56

99.65

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

117

10.03

99.32

3.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

113

115

10.11

99.05

3.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

113

115

10.11

99.05

3.1

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

1266

3.33

95.96

2.6

2.5

g/l

9.5

10.3

1.94

352

1076

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

355

1088

3.51

95.66

2.7

3.5

ratio

7.5

3.0

0.34

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

337

1004

3.60

94.80

2.6

2.4

g/l

0.1

0.0

0.36

323

916

(3018677) aPTT in Platelet poor plasma by Coagulation assay

978

5134

2.24

91.86

3.1

2.1

29.4

30.0

1.98

950

4979

(3042936) Bacteria identified in Isolate by Culture

888

4488

2.30

91.32

2.0

—

(3032080) INR in Blood by Coagulation assay

1974

13513

2.02

90.47

10.4

10.6

inr

1.2

1.3

4.95

540

3755

(3042631) Mycobacterium sp identified in Specimen

214

480

4.68

88.58

2.1

2.8

—

(3033658) Prothrombin time (PT) actual/Normal

1306

7764

2.07

88.29

5.9

4.1

85.4

86.0

0.38

1277

7588

(3016650) Hepatitis A virus Ab [Presence] in Serum

190

390

5.09

87.40

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

155

7.97

87.32

3.1

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

155

7.97

87.32

3.1

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

120

155

7.97

87.32

3.1

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

120

155

7.97

87.32

3.1

1.6

—

(40768804) Tissue Pathology biopsy report

1768

11746

1.99

87.08

2.6

2.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

260

691

3.98

86.16

1.9

1.3

mg/l

626.0

544.3

1.48

252

650

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

225

6.48

84.70

2.1

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

131

194

6.97

84.47

2.2

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

306

925

3.52

83.95

2.8

2.4

g/l

0.0

0.00

296

855

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

308

939

3.49

83.38

2.8

2.4

g/l

0.0

0.07

296

856

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

156

280

5.78

83.19

2.2

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

236

600

4.14

83.07

2.1

1.5

e6/l

8805.1

853.4

0.46

208

491

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

236

600

4.14

83.07

2.0

1.4

e6/l

23.5

25.3

0.05

204

464

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

130

195

6.88

82.83

2.2

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

328

1047

3.35

82.56

2.7

2.3

g/l

36.5

37.5

1.89

305

900

(3044290) Cell count panel - Cerebral spinal fluid

221

544

4.26

81.19

2.0

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

433

1642

2.86

80.84

2.1

1.7

g/l

1.6

1.5

0.20

361

1409

(40760888) Immunoglobulin light chains.free panel - Serum

283

849

3.53

78.44

2.7

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

282

851

3.51

77.44

3.4

2.5

g/l

3.8

3.5

1.30

273

805

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

311

1004

3.30

76.73

1.7

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

695

3405

2.29

75.37

4.6

2.8

umol/l

7.7

9.3

1.25

627

2995

(3013826) Glucose [Moles/volume] in Serum or Plasma

2405

18313

1.94

73.48

8.0

4.9

mmol/l

6.7

6.9

3.82

2339

17234

(3019832) Treponema pallidum Ab [Presence] in Serum

329

1162

3.02

69.52

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

11.66

68.97

2.5

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

219

611

3.75

67.50

1.9

1.3

mmol/l

3.7

3.9

1.31

208

571

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

181

441

4.27

67.28

6.0

6.7

mg/l

11.2

12.1

2.14

166

412

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

20.68

67.16

1.8

2.5

mg/l

1.5

1.1

0.27

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

124

7.76

67.14

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

148

308

4.97

66.89

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

172

409

4.37

65.98

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

210

586

3.74

64.68

6.8

3.4

56.5

57.9

0.62

210

586

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

16.60

64.24

1.4

1.8

—

(3028433) Virus identified in Specimen by Culture

8.87

63.91

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

17.57

63.62

1.1

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1189

7495

1.88

63.02

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

145

322

4.65

60.60

3.5

2.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

174

6.06

58.41

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

271

946

3.02

58.23

1.7

—

(36304419) Bacteria [Presence] in Urine

1292

8532

1.80

57.75

3.8

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1331

8872

1.79

57.61

3.8

3.3

e6/l

0.5

0.02

1043

6773

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

174

6.00

57.28

1.7

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1479

10197

1.76

56.78

3.7

3.2

ng/l

1854.8

1631.1

1.13

1357

8829

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

10.87

56.63

1.7

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2472

19728

1.81

56.58

5.5

4.8

e6/l

1422.5

1602.1

0.06

318

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

172

459

3.88

56.42

1.3

miu/ml

129.0

216.2

1.65

178

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

434

1952

2.39

56.27

1.8

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1421

9735

1.76

55.41

3.9

3.4

e6/l

35.6

81.2

3.94

1140

7595

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

786

4481

1.96

55.41

2.5

2.7

23.6

22.4

1.21

704

3812

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

226

730

3.24

55.39

2.0

1.8

mg/l

11.3

11.8

0.35

216

665

(3004789) Transferrin [Mass/volume] in Serum or Plasma

817

4739

1.94

54.63

2.4

2.6

g/l

2.2

2.3

7.41

768

4391

(3018095) Leukocytes [#/volume] in Urine

1561

11035

1.73

54.05

4.5

3.9

e6/l

137.7

117.2

0.18

1193

8075

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

647

3474

2.05

53.88

2.3

4.0

ug/l

10.5

21.5

1.29

452

2890

(3022948) Iron [Moles/volume] in Serum or Plasma

854

5099

1.88

51.94

2.5

2.6

umol/l

12.9

12.5

0.53

806

4732

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

100

185

5.53

51.57

2.9

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1209

8131

1.73

48.81

2.2

2.3

mg/l

3.4

3.0

3.44

1048

6902

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

304

1247

2.57

47.82

3.4

3.0

u/ml

0.4

0.3

0.32

194

708

(3000991) Gas panel - Venous blood

538

2823

2.06

47.22

8.3

8.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

233

4.61

43.92

1.1

—

(3000494) Fungus identified in Specimen by Culture

618

3488

1.93

43.83

1.8

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.83

43.16

1.4

1.1

—

(3002032) Base excess in Venous blood by calculation

573

3171

1.96

43.00

5.6

3.8

mmol/l

2.0

0.03

474

2555

(3016018) Differential panel - Cerebral spinal fluid

116

284

4.19

42.80

1.9

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

112

267

4.30

42.79

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

9.73

42.15

2.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.37

41.96

1.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

285

1208

2.48

41.71

1.9

1.8

u/l

43.1

38.2

2.81

254

1033

(3012544) pH of Venous blood

584

3300

1.92

41.05

5.6

3.8

7.4

—

(3000850) Epithelial cells [#/volume] in Urine

1024

6842

1.69

40.87

3.1

2.7

e6/l

3.8

4.8

3.47

926

5994

(3021447) Carbon dioxide [Partial pressure] in Venous blood

567

3182

1.93

40.65

5.7

3.8

kpa

5.7

5.8

2.28

556

3075

(3020779) Urea [Moles/volume] in Serum or Plasma

561

3139

1.93

40.58

7.8

7.3

mmol/l

10.3

10.5

0.24

546

2978

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.36

39.83

1.8

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

7.93

39.60

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

494

2675

1.98

39.24

10.6

4.0

mmol/l

1.2

1.01

482

2352

(3009343) pH of Capillary blood

424

2181

2.07

38.84

4.7

3.8

7.4

3.00

281

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

413

2104

2.09

38.83

4.6

3.7

mmol/l

2.3

1.8

2.20

343

1527

(3026782) Osmolality of Urine

963

6410

1.69

38.60

3.3

2.9

mosm/kgh2o

537.4

552.2

1.51

867

5454

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

426

2213

2.05

37.95

4.7

3.8

kpa

5.0

5.2

2.99

409

2039

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

184

662

2.88

37.27

1.2

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1547

11666

1.57

36.77

3.2

2.9

ug/l

400.6

152.9

19.50

1440

10618

(3025941) Bacteria identified in Stool by Culture

313

1462

2.25

36.60

1.4

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

274

1224

2.34

35.57

2.0

3.2

u/ml

207.8

4340.8

1.11

220

1044

(3009871) Measles virus Ab [Titer] in Serum

7.75

35.27

1.9

1.5

—

(3000012) Reticulocyte production index

183

4.62

35.02

1.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

103

268

3.93

35.01

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1306

9595

1.57

34.07

2.9

2.6

u/l

52.5

58.9

4.88

1212

8835

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

791

5146

1.69

33.92

3.3

3.1

e6/l

1.7

1.9

0.31

448

2889

(3037467) Urinalysis macro (dipstick) panel - Urine

2422

20406

1.57

33.72

5.4

4.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

928

6318

1.63

33.24

2.2

1.7

mg/l

2.0

1.4

2.22

755

4922

(3025468) Yersinia sp identified in Specimen by Organism specific culture

125

384

3.34

33.19

2.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

125

384

3.34

33.19

2.7

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

179

675

2.74

33.17

2.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.55

33.10

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

125

386

3.32

32.91

2.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

824

5471

1.66

32.50

3.2

2.9

e6/l

1.0

1.1

0.71

477

3192

(3024522) Salmonella sp identified in Specimen by Organism specific culture

125

390

3.28

32.37

2.7

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

132

5.15

32.28

3.3

5.9

u/ml

39.6

58.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

388

3.27

31.97

2.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

125

394

3.25

31.84

2.7

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.20

31.78

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

463

2628

1.87

31.54

2.1

2.2

nmol/l

371.4

371.2

0.01

443

2392

(3014111) Lactate [Moles/volume] in Serum or Plasma

510

2989

1.82

31.35

7.4

6.9

mmol/l

1.5

1.4

1.72

494

2867

(3026008) Bacteria identified in Urine by Culture

1276

9466

1.54

31.16

3.6

3.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

931

6429

1.60

31.13

4.2

3.9

ng/l

319.4

561.8

0.52

813

5389

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

319

1607

2.08

30.66

6.9

4.1

mmol/l

24.6

24.2

1.12

298

1438

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

162

4.58

30.58

2.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

162

4.58

30.58

2.2

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

385

2077

1.96

30.55

2.2

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

286

1387

2.15

30.35

3.4

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

104

301

3.53

30.31

1.3

2.1

u/l

157.3

2576.7

1.88

119

(3014576) Chloride [Moles/volume] in Serum or Plasma

665

4253

1.69

29.99

9.2

6.8

mmol/l

104.3

104.4

0.22

642

4151

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

196

816

2.48

29.70

6.2

3.5

mg/l

1.5

1.7

1.27

181

736

(3022313) Gas panel - Capillary blood

312

1578

2.07

29.64

5.2

3.9

—

(3023419) Bacteria identified in Sputum by Culture

130

441

3.02

29.27

1.8

2.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

173

4.35

29.05

3.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

503

3006

1.78

28.82

2.2

g/l

0.2

4.38

465

2803

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

14.54

28.79

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

222

3.90

28.78

2.1

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

264

3.59

27.92

1.5

1.4

g/l

2.1

3.0

4.05

184

(3024139) IgG subclass 3 [Mass/volume] in Serum

264

3.59

27.92

1.5

1.4

g/l

0.3

0.4

1.80

185

(3027135) IgG subclass 1 [Mass/volume] in Serum

264

3.59

27.92

1.5

1.4

g/l

6.0

6.8

0.79

185

(3017732) Neutrophils [#/volume] in Blood

355

1926

1.94

27.60

3.1

3.3

e9/l

4.0

4.2

0.36

260

1421

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

130

456

2.92

27.59

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

220

3.84

27.53

2.1

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1554

12248

1.47

27.21

4.6

4.0

ng/l

40.7

91.7

0.80

1311

9230

(3002256) Pathology report gross observation

619

3978

1.67

27.16

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

140

517

2.78

27.02

1.7

1.5

g/l

31.2

31.7

0.17

132

465

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

109

350

3.18

26.96

1.4

1.3

u/l

364.6

324.5

0.28

334

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1515

11897

1.47

26.94

2.4

2.2

nmol/l

78.6

0.02

1408

10476

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

124

435

2.92

26.32

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

267

1331

2.09

26.31

5.6

4.1

mmol/l

25.7

24.8

4.90

253

1225

(3024980) IgG subclass 4 [Mass/volume] in Serum

121

421

2.94

26.07

1.5

1.7

g/l

0.5

0.9

4.44

320

(4062490)

267

3.47

26.01

1.5

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

565

3586

1.68

25.89

1.9

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

540

3392

1.70

25.71

6.1

3.6

—

(3019225) pH of Specimen

525

3283

1.70

25.40

7.7

4.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1220

9262

1.48

25.34

6.4

3.2

u/l

36.0

38.4

0.43

1165

8780

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.49

24.88

1.2

—

(3023410) Appearance of Cerebral spinal fluid

267

3.39

24.59

2.6

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3123

28667

1.67

23.66

39.6

16.2

mg/l

24.7

26.2

1.91

2915

23169

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

252

1283

2.04

23.43

2.4

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

182

817

2.29

23.29

1.5

1.6

iu/ml

1.3

12.7

0.79

169

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

154

658

2.40

22.07

1.4

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

13.20

21.97

2.3

6.9

—

(3012441) Differential panel - Pleural fluid

110

400

2.81

21.90

1.7

1.5

—

(40768806) Pleura Pathology biopsy report

111

408

2.78

21.66

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

133

4.26

21.60

1.5

1.2

66.6

65.1

0.04

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

446

2788

1.68

21.39

2.4

u/l

36.8

55.7

0.56

382

2375

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

160

720

2.28

20.38

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

160

720

2.28

20.38

1.5

1.3

—

(3024471) HLA-A [Type]

5.11

20.23

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.17

20.03

1.3

1.2

16.3

23.9

0.26

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

170

791

2.21

19.98

3.9

2.5

226.8

198.6

3.16

161

758

(3036489) Thrombin time

215

1095

2.02

19.95

3.3

2.1

22.8

21.6

1.22

202

994

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

121

487

2.54

19.74

1.2

1.1

—

(3024932) HLA-DR beta [Type]

4.98

18.75

1.4

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

27.95

18.70

1.7

3.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

270

3.01

18.27

1.3

u/l

32.7

12.1

1.25

247

(3001686) Cold agglutinin [Titer] in Serum or Plasma

5.62

18.19

1.7

1.3

titre

45.0

128.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

160

758

2.16

17.99

1.7

1.5

g/l

0.2

1.31

145

722

(3003396) Base excess in Arterial blood by calculation

576

3986

1.53

17.87

9.2

7.1

mmol/l

1.5

1.1

1.52

450

3094

(40768797) Stomach Pathology biopsy report

594

4143

1.52

17.76

1.4

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

574

3989

1.52

17.43

9.2

7.1

kpa

12.2

12.1

0.33

548

3795

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

7.79

17.42

1.4

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

574

3990

1.52

17.41

9.2

7.1

kpa

5.0

5.1

2.43

543

3794

(3016502) Oxygen saturation in Arterial blood

528

3609

1.54

17.30

9.8

7.4

95.9

95.4

1.57

508

3469

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

162

785

2.11

17.20

1.7

1.5

g/l

1.1

1.2

1.31

156

745

(3023199) Leukocytes [#/volume] in Pleural fluid

110

454

2.47

17.06

1.6

1.4

e6/l

2074.9

1828.6

0.28

328

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.98

17.02

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.98

17.02

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.98

17.02

1.3

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

103

415

2.53

16.81

1.5

1.4

e6/l

25807.9

82287.0

1.69

241

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

216

3.14

16.58

1.4

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

359

2.60

16.05

1.5

1.4

mmol/l

6.1

6.5

0.74

335

(3019060) Gas panel - Arterial blood

364

2327

1.63

15.82

7.9

4.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

120

534

2.29

15.75

1.7

1.4

u/l

10.5

9.6

0.30

104

432

(1616796) Gas panel - Central venous blood

157

778

2.06

15.73

3.9

4.1

—

(3048879) Bone marrow aspiration report

108

4.02

15.48

2.0

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

3.93

15.37

1.2

1.1

ng/l

2092.4

433.4

0.88

(3024354) Oxygen [Partial pressure] in Venous blood

397

2620

1.58

15.09

5.6

3.2

kpa

4.7

4.5

0.56

385

2525

(21494890) Protein electrophoresis panel - 24 hour Urine

377

2.51

15.02

1.9

2.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

206

1142

1.85

14.89

2.4

3.6

u/ml

98.7

75.4

0.47

198

1097

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

8.04

14.89

3.5

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

8.04

14.89

1.7

3.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

140

3.53

14.71

1.3

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

25.12

14.67

1.6

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2029

17802

1.32

14.50

4.0

3.2

u/l

62.5

55.0

2.09

1888

16300

(3002173) Hemoglobin [Mass/volume] in Arterial blood

474

3296

1.50

14.17

10.6

7.8

g/l

111.8

121.1

17.96

455

3175

(40761536) Microorganisms panel - Urine sediment

377

2495

1.57

14.13

4.8

4.2

—

(3012501) Base excess in Blood by calculation

151

772

2.00

13.92

4.3

4.9

mmol/l

2.8

2.7

0.14

116

542

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

223

2.90

13.90

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.03

13.85

1.3

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

978

7770

1.36

13.79

1.6

nmol/l

19.3

20.3

1.20

852

6558

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

157

818

1.96

13.71

1.2

1.4

—

17.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1664

14277

1.31

13.65

4.3

3.8

estimate

0.0

0.00

411

2698

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

479

3367

1.49

13.55

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

3.34

13.53

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

11.71

13.53

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.89

13.51

1.3

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.89

13.51

13.0

3.3

umol/l

44.9

40.6

0.37

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

4.20

13.40

1.9

1.5

ug/l

1.5

3.0

2.04

(3024891) Influenza virus A+B Ag [Presence] in Specimen

136

680

2.04

13.34

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

180

3.09

13.33

1.2

1.1

mg/l

72.7

40.2

2.07

149

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

186

1035

1.84

13.31

1.6

titre

435.0

272.7

—

(3020393) Adenovirus Ag [Presence] in Stool

7.34

13.12

1.7

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.78

13.06

1.7

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

265

2.67

13.04

1.3

1.1

u/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

306

2.55

13.01

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

132

3.44

13.01

31.8

26.5

ug/l

106.5

115.9

0.46

109

(3037522) Nuclear Ab [Titer] in Serum

491

3496

1.47

12.99

1.3

titre

745.7

520.4

1.19

109

758

(3023323) Follitropin [Units/volume] in Serum or Plasma

112

526

2.17

12.96

1.7

1.4

iu/l

28.9

30.1

0.13

442

(3010937) Rubella virus Ab [Presence] in Serum

28.45

12.95

1.1

1.2

—

(3013862) HLA-DP [Type]

22.60

12.88

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

6.70

12.74

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

2535

23136

1.32

12.68

43.3

19.8

14.5

13.8

81.99

2510

22583

(3035880) pH of Pleural fluid

213

2.85

12.63

1.5

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

9.41

12.54

1.1

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

265

1662

1.64

12.40

3.8

3.4

mmol/l

25.1

25.2

0.20

259

1608

(3015235) Bicarbonate [Moles/volume] in Capillary blood

170

941

1.85

12.38

3.1

3.2

mmol/l

24.3

24.9

0.88

155

819

(3026389) Candida sp identified in Specimen by Organism specific culture

358

2.38

12.24

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

175

3.00

12.05

1.2

1.0

mg/l

424.6

296.9

1.25

151

(46236302) HLA-C [Type] by High resolution typing

21.34

11.99

1.0

—

(40760410) HLA-B [Type] by High resolution

21.34

11.99

1.0

—

(40760409) HLA-A [Type] by High resolution

21.34

11.99

1.0

—

(40763590) HLA-DQ beta [Type]

21.34

11.99

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.67

11.94

1.8

1.2

ng/l

81.0

112.9

0.19

(21491868) Cryoglobulin [Mass/volume] in Serum

111

3.54

11.83

1.9

1.2

g/l

1.6

0.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

11.46

1.0

0.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

6.70

11.46

1.0

—

(40757373) Influenza virus identified in Isolate

3.98

11.46

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.67

11.40

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

1645

14306

1.28

11.36

5.7

5.1

estimate

0.0

0.50

420

2725

(3010421) pH of Blood

162

908

1.82

11.36

4.3

4.7

7.4

1.75

149

760

(3028626) Oxygen [Partial pressure] in Capillary blood

153

845

1.85

11.25

3.4

3.1

kpa

8.0

0.07

145

774

(3001893) Eosinophils/100 leukocytes in Pleural fluid

130

3.26

11.21

2.0

1.5

2.1

2.6

0.15

112

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2604

27859

0.76

11.06

4.3

4.7

mmol/l

1.4

15.00

2326

25235

(3008152) Bicarbonate [Moles/volume] in Arterial blood

324

2188

1.53

11.05

10.9

6.8

mmol/l

24.9

24.5

0.79

302

2043

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

466

2.13

11.04

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

152

3.05

11.03

1.9

1.4

66.4

67.8

0.09

124

(3021901) Oxygen saturation in Capillary blood

131

694

1.92

10.96

3.1

2.9

—

(3047189) Immunofixation for 24 hour Urine

174

2.90

10.95

1.6

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1659

14486

1.27

10.93

4.4

3.9

estimate

0.0

0.22

405

2630

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

245

1557

1.62

10.88

4.7

2.6

0.7

0.6

1.40

237

1489

(3052851) Hemolysis interference index of Serum or Plasma

164

936

1.79

10.84

4.0

3.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

118

3.33

10.80

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.31

10.75

1.1

1.2

mmol/l

3.4

2.2

0.33

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2520

27048

0.77

10.74

5.8

6.4

mmol/mol

40.5

40.6

0.28

2266

24718

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

3.03

10.64

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

807

6439

1.33

10.62

1.8

nmol/l

1210.2

1171.4

0.54

640

4800

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2635

28103

0.77

10.53

4.4

4.7

mmol/l

4.5

1.93

2380

25649

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

162

2.93

10.49

1.2

1.0

—

(3013512) EKG study

1129

9442

1.29

10.44

5.0

4.3

—

(40768443) Skin Pathology biopsy report

215

1339

1.64

10.36

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

18.82

10.25

1.5

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.55

10.23

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.72

10.23

1.2

1.3

—

(3024316) Viscosity of Plasma

7.80

10.14

2.9

1.4

mpas

1.7

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

294

2.37

10.13

1.2

u/l

57.5

58.5

0.05

197

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2711

28772

0.77

10.11

4.8

5.3

mmol/l

2.6

0.29

2418

26104

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

234

1499

1.60

10.07

2.6

3.3

pmol/l

4.2

4.4

2.60

211

1299

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

425

3084

1.43

10.06

3.2

3.0

ng/l

278.5

217.8

1.58

394

2828

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

100

497

2.04

10.06

1.3

—

(3045788) Cell count panel - Pleural fluid

359

2.23

9.99

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.10

9.92

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

608

4697

1.35

9.88

26.8

28.2

inr

1.3

1.4

0.84

652

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

620

7851

0.75

9.74

1.7

1.6

mmol/l

1.4

1.43

528

6495

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

7.39

9.70

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

280

1885

1.53

9.69

13.8

9.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

348

2450

1.47

9.68

3.7

4.0

ng/l

88.5

96.5

0.80

295

2094

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

296

2.32

9.53

1.2

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

113

3.21

9.44

28.4

31.2

ug/l

7.0

7.2

0.28

(3027974) Hepatitis B virus e Ag [Presence] in Serum

8.60

9.34

1.3

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

135

763

1.80

9.27

3.4

2.6

14.6

16.1

4.39

399

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

131

739

1.80

9.06

2.1

3.4

u/ml

738.9

747.2

0.00

116

679

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.19

8.98

1.7

1.2

mg/l

0.1

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

2.77

8.96

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.56

8.94

1.1

miu/ml

905.1

1623.7

3.34

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

2.82

8.84

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

2.82

8.84

1.1

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1686

14987

1.23

8.73

2.9

2.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

234

1552

1.54

8.68

4.5

4.0

49.2

48.4

0.20

234

1532

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

2.42

8.63

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

131

2.92

8.53

1.4

5.9

mg/l

69.8

64.8

0.09

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1141

9740

1.25

8.50

2.2

u/l

163.5

217.8

1.87

1081

9104

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.48

8.46

1.7

1.2

mg/l

1.9

2.9

—

(3017704) Immunofixation for Urine

195

2.53

8.38

1.4

1.6

—

(3020891) Body temperature

208

1359

1.56

8.26

6.1

4.6

—

(4027681)

134

2.86

8.21

1.3

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

3.07

8.12

1.4

1.3

ug/l

1.4

449.4

1.11

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

4.54

8.11

1.7

2.0

ng/l

117.4

114.2

0.04

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

135

2.83

8.10

1.3

1.0

u/l

1.2

0.03

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

17.20

8.07

1.7

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

112

626

1.81

8.02

1.2

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

22.06

8.01

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

135

801

1.71

7.88

1.4

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

356

2.07

7.81

3.3

3.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

136

811

1.70

7.80

1.4

1.2

—

(3044889) 12 lead EKG panel

2279

21035

1.23

7.78

5.0

4.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.65

7.73

2.0

1.5

4.8

5.0

0.03

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2863

27105

1.27

7.72

33.1

15.4

ml/min/173m2

76.7

76.0

0.93

2605

22464

(3029937) Albumin [Presence] in Urine by Test strip

934

7865

1.25

7.71

5.0

4.2

estimate

0.0

0.31

391

2581

(3022145) Colonoscopy Study observation

434

3303

1.36

7.69

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

3.44

7.66

1.9

2.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

816

1.69

7.64

1.4

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

7.35

7.55

1.4

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

4.10

7.53

1.3

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

131

782

1.70

7.50

2.7

2.2

g/l

119.3

128.3

3.44

573

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

13.37

7.38

1.2

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

187

1225

1.56

7.37

4.9

3.8

mmol/l

1.6

1.4

0.92

181

1206

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.39

7.24

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

128

768

1.69

7.21

1.9

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

237

1644

1.47

7.13

1.3

au/ml

83.8

56.3

—

(3037121) Protein [Mass/volume] in Urine

171

1109

1.57

7.06

2.8

3.1

g/l

0.7

0.3

0.75

458

(3047181) Lactate [Moles/volume] in Blood

166

1070

1.58

7.04

12.0

6.2

mmol/l

1.3

0.03

140

943

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

13.79

6.88

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

13.79

6.88

1.1

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

260

1851

1.44

6.84

9.2

9.1

mmol/l

24.4

24.3

0.12

246

1722

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

628

1.74

6.83

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2554

26963

0.82

6.61

4.0

4.2

mmol/l

1.3

2.35

2282

24210

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.18

6.56

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

320

2.02

6.47

1.2

u/ml

61.3

47.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

185

2.34

6.31

2.9

3.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

254

1831

1.42

6.25

2.5

2.4

au/ml

38.0

22.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

334

2524

1.36

6.19

3.4

2.8

ml/min/173m2

58.7

62.4

0.87

134

1062

(3051651) Icteric interference index of Serum or Plasma

175

2.36

6.13

5.2

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3128

30131

1.29

6.11

38.7

19.2

mmol/l

139.4

139.6

7.57

3088

29349

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1470

13196

1.19

6.08

2.1

pmol/l

91.0

93.5

1.20

860

6870

(3005322) IgE [Units/volume] in Serum or Plasma

215

1512

1.45

6.07

1.3

u/ml

539.3

231.3

1.03

186

1389

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

2.59

6.03

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

116

714

1.65

5.99

2.5

2.7

umol/l

33.0

36.1

0.61

101

594

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.88

5.98

1.2

68.4

55.9

0.49

(3051611) Lipemic interference index of Serum or Plasma

309

1.99

5.98

4.3

3.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

118

2.64

5.89

1.3

1.4

mmol/l

3.5

3.3

0.12

107

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

137

2.50

5.77

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

568

1.71

5.76

1.3

1.2

u/ml

1.4

7.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.08

5.76

1.1

1.2

mmol/l

1.4

1.6

0.56

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

592

1.69

5.72

1.3

u/l

96.8

44.2

1.63

514

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

288

1.99

5.64

1.1

—

2.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

4.07

5.62

1.1

g/l

15.4

15.9

0.11

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

2.71

5.59

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

166

1130

1.49

5.55

1.4

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

177

2.27

5.55

1.9

1.5

nmol/l

0.2

0.3

0.91

134

(3043409) Potassium [Moles/volume] in Arterial blood

155

1041

1.51

5.53

5.5

4.0

mmol/l

3.8

3.9

1.13

137

966

(3023103) Potassium [Moles/volume] in Serum or Plasma

3128

30198

1.27

5.52

39.4

19.4

mmol/l

4.0

0.38

3084

29370

(3003740) Influenza virus B Ag [Presence] in Specimen

278

1.99

5.45

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

805

6893

1.22

5.42

4.2

3.8

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.55

5.32

1.4

20.7

17.7

0.12

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.92

5.29

1.1

—

(40758358) Immune stain study

11.27

5.29

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

202

1443

1.42

5.27

10.1

5.1

1.6

0.35

184

1349

(3028468) Fragments [Presence] in Blood by Light microscopy

+∞

5.21

1.0

0.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.23

5.16

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.21

5.09

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

217

2.09

5.09

4.9

5.1

u/ml

38.8

44.1

0.07

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.85

5.08

1.1

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

165

2.26

5.07

1.9

1.2

—

(1761868) Lipid panel - Serum or Plasma

762

8821

0.83

5.04

3.0

3.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.77

5.03

2.9

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

153

2.30

5.02

5.6

6.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

280

1.94

5.01

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.67

4.90

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

2.43

4.87

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

534

1.66

4.87

3.0

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

196

1422

1.40

4.72

10.9

5.2

0.9

0.19

179

1331

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

2.21

4.71

1.9

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

116

1726

0.66

4.63

1.7

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

2633

25108

1.18

4.60

34.7

17.5

37.1

39.2

21.52

1683

16430

(3020356) Listeria sp identified in Specimen by Organism specific culture

14.02

4.57

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.83

4.53

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3134

30389

1.24

4.49

24.1

11.1

u/l

26.9

26.2

0.79

3092

29131

(3018572) Chloride [Moles/volume] in Blood

117

781

1.51

4.37

15.5

6.9

mmol/l

105.0

105.2

0.09

101

695

(3039000) Anion gap in Blood

117

781

1.51

4.37

15.5

6.9

mmol/l

10.7

11.3

1.25

101

695

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.91

4.28

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.88

4.25

1.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

363

1.75

4.25

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

195

1441

1.37

4.24

2.5

2.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

379

1.73

4.21

1.2

u/ml

3.1

4.2

0.38

127

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

109

723

1.52

4.21

1.4

1.2

u/ml

44.8

38.0

0.14

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

103

676

1.54

4.18

1.4

1.2

u/ml

2.0

3.9

1.57

(3028679) Herpes simplex virus Ab [Presence] in Serum

103

2.44

4.13

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

825

1.48

4.11

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

161

2.12

4.09

2.1

1.6

u/field

1.3

2.5

1.22

116

(4212803)

3.76

4.08

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

499

1.62

4.04

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

165

1197

1.40

4.02

2.0

2.2

ug/l

406.9

652.6

0.48

154

1131

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.02

4.01

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

10.02

4.01

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.02

4.01

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

103

686

1.52

3.93

1.4

1.2

u/ml

2.0

6.3

1.78

105

(3024869) Neuronal Ab [Presence] in Serum

2.97

3.84

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

498

1.60

3.84

1.3

1.2

u/ml

28.4

45.6

0.59

(40768441) Liver Pathology biopsy report

200

1.96

3.81

1.1

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.76

3.77

2.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.76

3.77

2.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.02

3.76

1.2

1.0

u/field

1.2

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.48

3.62

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

190

1.96

3.62

1.9

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.26

3.62

1.7

1.5

—

(3036603) Volume of Urine

197

1.94

3.62

1.6

1819.9

1664.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

368

1.67

3.55

1.2

u/ml

3.1

5.7

1.57

160

(3000570) Elastase.pancreatic [Mass/mass] in Stool

128

910

1.42

3.54

1.5

1.4

ug/g

251.3

273.0

0.61

553

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1202

10972

1.14

3.48

4.7

4.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

2.22

3.41

3.4

2.4

—

(3019977) pH of Arterial blood

202

1.89

3.38

4.6

2.6

7.4

0.04

(3008295) Osmolality of Serum or Plasma

329

1.68

3.32

1.3

mosm/kgh2o

272.9

276.4

0.68

244

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.03

3.25

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

222

2801

0.78

3.24

1.5

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

107

754

1.43

3.14

1.2

titre

109.2

95.0

0.22

(3041096) Erythrocytes [Presence] in Urine by Automated

841

7544

1.15

3.09

4.2

3.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

947

10413

0.88

3.00

4.0

mg/mmol

10.6

9.3

0.38

611

6666

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.01

2.97

1.0

1.2

—

(4015189)

2.24

2.96

1.3

2.1

—

(3025130) Human papilloma virus identified in Specimen

183

1.87

2.95

2.1

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.38

2.89

1.5

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3118

30449

1.18

2.86

42.2

19.2

umol/l

84.2

82.4

1.59

3118

30438

(4268621)

260

1.70

2.83

2.1

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

766

6874

1.15

2.78

1.7

pmol/l

18283467.7

28081519.6

0.21

629

5623

(3045414) Leukocytes [Presence] in Urine

173

1347

1.30

2.75

2.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.31

2.74

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.24

2.70

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1094

0.69

2.69

1.4

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.98

2.69

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

182

1.82

2.69

1.7

1.6

u/l

9.0

6.5

0.23

(40759836) Histone Ab [Presence] in Serum by Immunoblot

190

1.80

2.66

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1.80

2.66

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1.80

2.66

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2218

21228

1.12

2.65

4.0

3.9

pmol/l

15.0

0.56

2008

18997

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

1.91

2.65

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

130

978

1.34

2.64

1.4

1.2

u/ml

6.7

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

2.63

1.2

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

7.15

2.55

1.2

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.77

2.54

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.77

2.54

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.77

2.54

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

790

0.65

2.45

1.5

1.7

mg/l

3.1

3.9

0.37

572

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.67

2.45

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

359

1.54

2.43

1.4

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

362

3101

1.19

2.41

2.3

2.4

ug/l

7.6

7.3

0.07

304

2706

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.76

2.37

3.6

5.6

—

(3003181) Sodium [Moles/volume] in Urine

609

1.41

2.36

1.5

1.3

mmol/l

57.3

62.9

0.70

491

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

2.03

2.36

6.8

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

2.03

2.36

6.8

2.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

387

1.51

2.33

6.1

24.2

mmol/l

7.5

7.6

0.04

320

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.48

2.27

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

725

1.36

2.26

7.5

3.0

—

(3034770) Mitochondria Ab [Titer] in Serum

101

753

1.35

2.23

1.2

—

1160.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

103

771

1.35

2.21

3.1

nmol/l

1.0

0.8

0.82

582

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

2.18

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

102

1.97

2.10

1.2

2.1

e6/l

14363.3

21547.4

0.15

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

642

0.65

2.08

1.2

1.6

nmol/l

1.0

0.8

0.48

526

(3034274) Bile acid [Moles/volume] in Serum --fasting

161

1.74

2.05

1.2

1.7

umol/l

4.9

13.3

1.23

105

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.50

2.05

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

181

1475

1.24

2.05

1.3

—

(21494755) Public health laboratory ask at order entry panel

120

1532

0.78

2.02

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

3008

29447

1.13

2.01

29.6

15.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.23

2.00

1.6

3.0

—

(3012516) Albumin [Mass/volume] in Urine

915

9875

0.90

1.99

3.4

3.3

mg/l

1165.1

283.6

3.05

598

6355

(3035320) C reactive protein [Mass/volume] in Body fluid

209

1.63

1.97

2.1

2.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.96

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

440

1.42

1.88

3.0

2.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.19

1.88

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.19

1.88

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.65

1.86

1.6

2.3

—

(40768446) Kidney Pathology biopsy report

107

1.87

1.86

1.1

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

317

1.49

1.85

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

426

1.42

1.82

2.1

2.2

mg/l

29.8

22.3

0.51

101

(3004451) EKG impression Narrative

175

1.66

1.82

1.4

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.67

1.72

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

125

1.76

1.71

2.4

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1.45

1.69

1.1

—

(3017569) Oxygen content in Arterial blood

179

1.63

1.69

1.8

2.3

—

(3016750) Collection duration of Urine

196

1.59

1.65

2.2

2.1

min

517.2

487.7

1.00

145

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.95

1.59

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.95

1.59

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.95

1.59

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.95

1.59

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.70

1.58

1.0

1.1

—

(1002224) Polysomnography panel

889

0.75

1.57

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

339

2999

1.14

1.56

2.3

ug/g

203.7

157.3

0.98

284

2350

(3039443) Prostate specific Ag panel - Serum or Plasma

600

0.70

1.55

1.6

1.7

—

(3002619) Bacteria identified in Specimen by Culture

2.11

1.55

1.6

1.1

—

(40761535) Cells panel - Urine sediment

307

2702

1.15

1.53

4.4

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

954

10159

0.92

1.52

3.2

mmol/l

7.1

7.5

1.59

786

8435

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

116

1.73

1.48

2.8

1.9

ug/l

37.0

57.0

1.38

111

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

442

3993

1.12

1.47

13.0

7.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1221

0.80

1.43

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.73

1.43

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

273

2398

1.15

1.41

2.5

2.2

nmol/l

13.0

12.6

0.33

248

2085

(44806420)

121

0.41

1.37

2.2

2.5

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.61

1.36

6.8

3.4

g/mol

14.3

30.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.61

1.36

1.0

2.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

162

0.49

1.35

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

299

1.41

1.33

1.0

u/ml

1.6

2.9

1.38

105

(4306422)

350

1.38

1.32

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

351

1.37

1.31

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.78

1.28

1.2

3.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

370

1.36

1.27

1.1

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

117

0.43

1.24

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

123

1.63

1.24

1.2

ratio

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.31

1.18

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

335

0.65

1.18

1.0

1.1

u/ml

14.3

2.0

—

145

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

214

1.45

1.18

1.2

—

115.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

133

1.58

1.17

1.1

—

(36660697) Celiac disease serology panel - Serum

226

1993

1.14

1.15

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

104

1249

0.83

1.12

1.3

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1006

10575

0.93

1.12

4.2

4.5

21.4

21.9

0.43

511

5460

(3017315) Amylase [Enzymatic activity/volume] in Urine

151

1.53

1.11

1.3

1.2

u/l

149.8

378.6

1.90

139

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.26

1.10

2.7

4.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.95

1.08

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

467

0.73

1.08

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

227

1.41

1.07

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

227

1.41

1.07

1.2

mmol/l

31.5

33.3

0.28

198

(3014891) Appearance of Pleural fluid

1.93

1.06

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

733

1.22

1.04

4.6

3.3

mmol/l

7.0

7.6

1.98

711

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.02

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.74

1.02

1.4

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

196

1.43

1.02

1.5

umol/l

15.6

14.1

0.49

183

(3034426) Prothrombin time (PT)

1.69

1.01

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

113

957

1.19

1.00

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

656

1.22

0.99

1.1

u/ml

4.5

7.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

285

0.66

0.99

1.0

1.1

u/ml

2.7

2.2

—

126

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

274

1.35

0.99

1.9

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.18

0.98

1.2

ml/s/173m2

1.7

0.9

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.95

0.97

6.3

4.9

ug/min

42.4

58.1

—

(3045716) Anion gap in Serum or Plasma

165

1.46

0.96

1.9

2.5

mmol/l

8.9

9.3

0.34

135

(3011648) Oxygen content in Venous blood

267

1.35

0.96

12.1

3.0

10.5

11.0

0.28

267

(44816559) Phosphatidylethanol [Mass/volume] in Blood

467

0.75

0.95

1.5

1.3

—

(4024509)

304

1.32

0.92

1.3

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

291

0.69

0.91

1.0

1.1

u/ml

12.4

4.9

—

145

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.60

0.90

1.4

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

1.38

0.90

1.4

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

271

1.33

0.89

2.3

2.0

u/field

2.1

2.2

0.01

(3001019) Free T4 and TSH panel - Serum or Plasma

805

0.82

0.88

1.6

1.7

—

(3044007) Cell count panel - Peritoneal fluid

1.58

0.87

1.5

2.1

—

(3000330) Specific gravity of Urine by Test strip

189

1688

1.13

0.85

3.7

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

104

891

1.17

0.84

4.8

4.3

—

(3008037) Lactate [Moles/volume] in Venous blood

780

1.18

0.84

4.4

3.2

mmol/l

1.6

0.38

756

(3044941) Cell count panel - Synovial fluid

511

0.78

0.82

1.6

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.88

0.81

2.0

1.9

umol/l

20.4

17.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

121

1385

0.87

0.80

1.4

1.8

—

(4146454)

385

0.75

0.79

2.7

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.82

0.79

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

462

0.78

0.77

1.1

iu/ml

1.2

59.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.76

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

32.0

—

(40768800) Prostate Pathology biopsy report

876

0.84

0.76

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

394

4216

0.93

0.74

1.2

u/ml

11.9

14.0

0.24

127

1538

(3010144) Erythrocytes [#/volume] in Synovial fluid

298

1.28

0.73

1.6

1.3

e6/l

13959.6

94754.8

1.55

208

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.58

0.71

1.1

73.7

85.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

101

1.49

0.70

1.2

2.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.71

0.70

7.6

14.6

mmol/l

8.8

5.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

574

1.19

0.69

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

135

1.41

0.69

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

1.85

0.68

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.56

0.68

1.1

1.3

78.0

83.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

110

1.46

0.68

3.0

2.8

umol/l

26.6

30.0

0.58

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

0.60

0.67

3.1

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

131

0.61

0.63

1.3

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

187

1705

1.10

0.63

2.4

2.5

—

(3028707) Methadone [Presence] in Urine by Screen method

223

0.72

0.62

1.2

2.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

138

1.38

0.62

1.4

1.3

mmol/l

6.0

6.2

0.21

132

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.60

0.61

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

235

1.28

0.61

1.3

1.1

u/ml

75.5

62.9

—

(3027944) Amphetamines [Presence] in Urine

466

0.81

0.60

1.2

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

344

1.22

0.59

1.5

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2781

28108

0.95

0.58

5.0

mmol/l

6.0

6.1

2.29

2516

25227

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1.38

0.57

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

474

0.82

0.57

1.2

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

266

2848

0.93

0.55

1.6

1.8

1.5

1.6

0.28

218

2437

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

293

1.23

0.55

1.4

34.1

27.4

0.47

176

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2627

25963

1.04

0.54

4.8

4.7

mu/l

3.1

2.0

0.49

2388

23347

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.54

0.53

1.8

2.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

181

0.72

0.52

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

704

1.14

0.52

4.0

3.6

mg/l

25.8

30.2

0.76

445

(3014051) Protein [Presence] in Urine by Test strip

723

1.14

0.52

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

0.68

0.51

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

579

5552

1.05

0.51

1.2

u/ml

2.1

1.8

0.24

126

1402

(3009466) Valproate [Moles/volume] in Serum or Plasma

413

0.82

0.51

3.4

4.8

umol/l

304.4

350.6

1.04

360

(3016879) Cocaine [Presence] in Urine

445

0.83

0.50

1.2

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

247

0.77

0.50

1.0

ng/l

768.7

686.0

0.26

158

(4281824)

270

1.22

0.49

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

246

0.77

0.49

1.0

ng/l

44.0

44.8

0.06

159

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

246

0.77

0.49

1.0

ng/l

321.1

312.7

0.06

163

(3027008) Opiates [Presence] in Urine

475

0.84

0.48

1.2

1.9

—

(4010399)

199

2140

0.93

0.48

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.49

0.47

1.0

1.1

—

78.9

—

(3004775) Volume in Urine collected for unspecified duration

282

1.21

0.46

2.3

2.2

826.3

630.5

0.98

181

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

120

1.33

0.46

1.0

1.1

iu/ml

123.1

238.0

2.05

120

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

118

0.68

0.45

1.9

1.8

nmol/l

2.0

8.9

—

101

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

449

0.84

0.44

1.2

1.7

—

(3022621) pH of Urine by Test strip

216

2024

1.07

0.43

3.1

3.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

396

1.16

0.42

1.0

1.1

g/l

1.7

1.5

1.74

351

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.42

1.8

2.6

u/field

0.4

0.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.43

0.41

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

477

0.86

0.41

1.1

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

268

1.20

0.40

1.2

1.6

u/ml

39.2

22.9

—

(3035941) MCH [Entitic mass]

3159

31406

1.05

0.40

52.6

23.7

30.5

30.4

2.08

3127

30853

(3024731) MCV [Entitic volume]

3159

31406

1.05

0.40

52.7

23.7

92.1

91.5

10.63

3127

30854

(3001729) Color of Synovial fluid

1.47

0.40

1.6

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

149

0.74

0.40

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.36

0.40

1.1

u/ml

4.4

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

3159

31408

1.05

0.40

52.9

23.8

e12/l

4.2

4.5

140.83

3092

30365

(3007461) Platelets [#/volume] in Blood

3158

31400

1.05

0.39

53.0

23.8

e9/l

216.0

242.9

74.33

3097

30471

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.3

—

365.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

196

1.23

0.39

2.1

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.38

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.39

0.38

1.0

1.2

umol/24h

2.1

1.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

3159

31415

1.05

0.38

53.1

24.0

g/l

124.7

134.8

187.59

3126

30863

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.34

0.38

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.34

0.38

1.1

1.4

—

(3010813) Leukocytes [#/volume] in Blood

3159

31416

1.04

0.37

52.9

23.8

e9/l

6.7

6.8

0.84

3094

30374

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

735

7559

0.97

0.37

2.8

3.2

ug/l

0.8

0.35

509

5306

(3027923) C peptide [Moles/volume] in Serum or Plasma

158

0.76

0.37

1.5

1.3

nmol/l

1.3

1.1

—

122

(40768793) Breast Pathology biopsy report

556

1.12

0.34

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.37

0.34

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

157

1472

1.07

0.34

1.2

iu/ml

137.5

138.9

0.01

521

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

133

0.75

0.33

1.7

1.3

—

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

166

0.78

0.33

1.4

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.30

0.33

1.0

1.1

—

75.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.67

0.33

1.3

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

1.24

0.32

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.33

0.30

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

174

1837

0.94

0.29

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

185

0.81

0.29

1.1

1.3

u/ml

0.4

1.2

—

(3014271) Vancomycin [Susceptibility]

194

1.19

0.29

2.4

2.9

—

(3008898) HLA-B27 [Presence]

689

1.09

0.28

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.32

0.28

1.1

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

374

1.12

0.28

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

379

3917

0.96

0.27

4.3

4.8

31.3

32.8

1.76

262

2552

(3024263) Appearance of Synovial fluid

183

0.82

0.27

1.5

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.21

0.26

7.3

7.6

—

(3020491) Glucose [Moles/volume] in Blood

225

0.84

0.26

1.3

2.0

mmol/l

7.9

6.8

0.76

149

(3006462) Nitrate [Presence] in Urine

150

1.20

0.26

2.8

4.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1300

13183

0.98

0.25

4.7

5.3

ug/l

2.9

3.8

1.02

1142

11774

(4211845)

160

1.19

0.25

2.7

3.9

—

(4094501)

830

0.93

0.25

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

406

1.11

0.25

1.6

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

311

1.13

0.25

3.6

3.2

mg/l

23.5

29.8

0.25

249

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.17

0.24

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.28

0.24

4.7

5.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

370

0.89

0.23

1.2

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

115

1.22

0.23

1.2

2.4

umol/l

108.1

111.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.25

0.22

2.0

2.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

11.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

182

1.15

0.21

1.4

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.16

0.21

1.0

1.3

nmol/l

11.0

5.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.21

0.0

1.0

—

89.3

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

872

0.94

0.20

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

303

0.89

0.20

1.3

mmol/l

7.8

7.5

0.14

223

(4034850)

933

0.94

0.20

12.7

10.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

136

1.18

0.20

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

850

0.94

0.19

2.6

2.3

ug/min

191.7

100.6

0.53

516

(3000285) Sodium [Moles/volume] in Blood

1.18

0.19

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

166

1.15

0.18

2.5

2.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.22

0.17

2.8

3.1

—

(4198724)

0.72

0.17

1.0

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.18

0.16

1.6

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

281

2881

0.97

0.15

1.4

—

(3020650) Glucose [Presence] in Urine

0.79

0.15

1.0

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.75

0.15

2.8

2.2

nmol/l

130.2

134.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.21

0.15

2.3

1.9

ug/l

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

605

1.06

0.15

2.0

1.8

iu/l

11.3

4.4

1.28

190

(3000492) Spirometry study

261

2546

1.03

0.14

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method

314

1.08

0.14

1.1

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

724

1.05

0.14

1.5

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

398

0.93

0.14

1.3

nmol/l

0.7

0.05

376

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.19

0.14

1.3

2.6

272.4

179.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

304

0.92

0.13

1.3

nmol/l

1.3

1.5

0.53

271

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

364

0.93

0.11

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

168

0.89

0.11

10.9

13.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

105

1.14

0.11

1.2

2.1

ug/l

266.4

96.8

0.28

(3032773) Endomysium IgG Ab [Titer] in Serum

192

1.09

0.10

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

198

0.91

0.10

1.0

1.2

mmol/l

14.1

12.3

—

(3003338) MCHC [Mass/volume]

2312

23203

0.99

0.10

46.1

21.2

g/l

331.2

332.2

5.46

2292

22996

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.04

0.09

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

642

6358

1.01

0.09

4.8

4.3

kg/l

1.0

0.40

105

977

(3023430) Cat dander IgE Ab [Units/volume] in Serum

196

0.92

0.09

1.0

1.1

u/ml

2.3

3.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.07

0.08

2.2

1.5

—

(4133840)

0.81

0.08

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

154

0.91

0.08

1.4

1.2

nmol/l

115.1

139.9

2.60

154

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

561

0.96

0.07

1.2

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.83

0.07

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

174

0.92

0.07

2.1

1.5

g/l

0.9

1.0

0.34

174

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

357

0.95

0.07

1.2

1.4

pmol/l

254.9

282.6

0.35

275

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.05

0.07

2.2

1.5

pmol/l

14.8

15.0

—

(3022689) Creatine [Moles/volume] in Urine

1.03

0.07

2.1

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

393

1.04

0.07

1.5

62.3

62.1

0.01

243

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

141

0.92

0.05

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

141

0.92

0.05

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

140

0.93

0.04

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

140

0.93

0.04

1.4

—

(3015183) Erythrocyte sedimentation rate

101

1.09

0.04

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

119

0.92

0.04

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.09

0.03

6.4

7.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

117

0.94

0.01

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

443

4444

1.00

0.01

1.2

1.3

iu/ml

53.0

37.7

0.81

142

1378

(3005033) Fetal Nuchal fold Thickness US

116

0.95

0.00

1.3

1.4

—

(44813793)

156

0.96

0.00

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

384

1.02

0.00

1.3

1.4

mu/l

48.8

67.6

0.45

340

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

1.02

0.00

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

152

0.99

0.00

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

218

1.01

0.00

1.3

1.4

promille

1.4

1.2

0.19

168

(3023511) Choriogonadotropin [Units/volume] in Urine

135

1.04

0.00

1.0

1.3

—

(3021788) Differential panel - Synovial fluid

575

1.01

0.00

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

191

0.99

0.00

1.7

1.4

pmol/l

82.6

192.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

351

1.00

0.00

1.3

nmol/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

764

0.99

0.00

1.9

1.6

e6/l

17078.7

14099.5

0.18

551

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

1.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.99

0.00

7.3

8.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

30.6

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

36.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.94

0.00

1.9

1.4

ug/l

11.9

9.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

0.88

0.00

1.3

mu/l

78.7

66.7

—

(4038314)

0.00

0.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1740.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

6.1

—

57.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

433.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-follicular lymphoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-follicular lymphoma (CD2_NONFOLLICULAR_LYMPHOMA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints